Article Versions Notes

Khandekar D, Dahunsi DO, Manzanera Esteve IV, Reid S, Rathmell JC, Titze J, Tiriveedhi V. Low-Salt Diet Reduces Anti-CTLA4 Mediated Systemic Immune-Related Adverse Events while Retaining Therapeutic Efficacy against Breast Cancer. Biology. 2022; 11(6):810. https://doi.org/10.3390/biology11060810

Khandekar, Durga, Debolanle O. Dahunsi, Isaac V. Manzanera Esteve, Sonya Reid, Jeffrey C. Rathmell, Jens Titze, and Venkataswarup Tiriveedhi. 2022. "Low-Salt Diet Reduces Anti-CTLA4 Mediated Systemic Immune-Related Adverse Events while Retaining Therapeutic Efficacy against Breast Cancer" Biology 11, no. 6: 810. https://doi.org/10.3390/biology11060810

Khandekar, D., Dahunsi, D. O., Manzanera Esteve, I. V., Reid, S., Rathmell, J. C., Titze, J., & Tiriveedhi, V. (2022). Low-Salt Diet Reduces Anti-CTLA4 Mediated Systemic Immune-Related Adverse Events while Retaining Therapeutic Efficacy against Breast Cancer. Biology, 11(6), 810. https://doi.org/10.3390/biology11060810